528 related articles for article (PubMed ID: 15185002)
21. Co-mutation of p53, K-ras genes and accumulation of p53 protein and its correlation to clinicopathological features in rectal cancer.
Pan ZZ; Wan DS; Chen G; Li LR; Lu ZH; Huang BJ
World J Gastroenterol; 2004 Dec; 10(24):3688-90. PubMed ID: 15534934
[TBL] [Abstract][Full Text] [Related]
22. p53 and K-ras gene mutations correlate with tumor aggressiveness but are not of routine prognostic value in colorectal cancer.
Tortola S; Marcuello E; González I; Reyes G; Arribas R; Aiza G; Sancho FJ; Peinado MA; Capella G
J Clin Oncol; 1999 May; 17(5):1375-81. PubMed ID: 10334521
[TBL] [Abstract][Full Text] [Related]
23. Mutation pattern of K-ras gene in colorectal cancer patients of Kashmir: a report.
Sameer AS; Chowdhri NA; Abdullah S; Shah ZA; Siddiqi MA
Indian J Cancer; 2009; 46(3):219-25. PubMed ID: 19574674
[TBL] [Abstract][Full Text] [Related]
24. Detection of K-ras point mutations in mesenteric venous blood from colorectal cancer patients by enriched polymerase chain reaction and single-strand conformation polymorphism analysis.
Fujita S; Sugano K; Fukayama N; Moriya Y; Sugihara K; Akasu T
Jpn J Clin Oncol; 1996 Dec; 26(6):417-21. PubMed ID: 9001346
[TBL] [Abstract][Full Text] [Related]
25. Alterations of K-ras and p53 mutations in colorectal cancer patients in Central Europe.
König EA; Köves I; Raşinariu A; Popp AR; Kusser WC; Soyonki K; Kovács A; Glickman BW; Jeney A; Marcsek ZL
J Toxicol Environ Health A; 2001 Mar; 62(5):333-47. PubMed ID: 11261896
[TBL] [Abstract][Full Text] [Related]
26. APC and p53 mutations in de novo colorectal adenocarcinomas.
Aoki T; Takeda S; Yanagisawa A; Kato Y; Ajioka Y; Watanabe H; Kudo S; Nakamura Y
Hum Mutat; 1994; 3(4):342-6. PubMed ID: 8081386
[TBL] [Abstract][Full Text] [Related]
27. Microsatellite instability-low colorectal cancer acquires a KRAS mutation during the progression from Dukes' A to Dukes' B.
Asaka S; Arai Y; Nishimura Y; Yamaguchi K; Ishikubo T; Yatsuoka T; Tanaka Y; Akagi K
Carcinogenesis; 2009 Mar; 30(3):494-9. PubMed ID: 19147861
[TBL] [Abstract][Full Text] [Related]
28. High sensitivity scanning of colorectal tumors and matched plasma DNA for mutations in APC, TP53, K-RAS, and BRAF genes with a novel DHPLC fluorescence detection platform.
Lilleberg SL; Durocher J; Sanders C; Walters K; Culver K
Ann N Y Acad Sci; 2004 Jun; 1022():250-6. PubMed ID: 15251969
[TBL] [Abstract][Full Text] [Related]
29. Detection of tumor mutant APC DNA in plasma of patients with sporadic colorectal cancer.
Ling E; Fich A; Man S; Wolfson M; Mikhailowsky R; Lamprecht SA
In Vivo; 2000; 14(4):543-6. PubMed ID: 10945171
[TBL] [Abstract][Full Text] [Related]
30. Molecular detection of genetic alterations in the serum of colorectal cancer patients.
Hibi K; Robinson CR; Booker S; Wu L; Hamilton SR; Sidransky D; Jen J
Cancer Res; 1998 Apr; 58(7):1405-7. PubMed ID: 9537240
[TBL] [Abstract][Full Text] [Related]
31. Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence.
Sanchez-Cespedes M; Esteller M; Hibi K; Cope FO; Westra WH; Piantadosi S; Herman JG; Jen J; Sidransky D
Clin Cancer Res; 1999 Sep; 5(9):2450-4. PubMed ID: 10499618
[TBL] [Abstract][Full Text] [Related]
32. p53 and APC mutations are detectable in the plasma and serum of patients with colorectal cancer (CRC) or adenomas.
Gocke CD; Benko FA; Kopreski MS; McGarrity TJ
Ann N Y Acad Sci; 2000 Apr; 906():44-50. PubMed ID: 10818595
[TBL] [Abstract][Full Text] [Related]
33. Dietary heme iron and the risk of colorectal cancer with specific mutations in KRAS and APC.
Gilsing AM; Fransen F; de Kok TM; Goldbohm AR; Schouten LJ; de Bruïne AP; van Engeland M; van den Brandt PA; de Goeij AF; Weijenberg MP
Carcinogenesis; 2013 Dec; 34(12):2757-66. PubMed ID: 23983135
[TBL] [Abstract][Full Text] [Related]
34. Analysis of the K-ras/B-raf/Erk signal cascade, p53 and CMAP as markers for tumor progression in colorectal cancer patients.
Georgieva M; Krasteva M; Angelova E; Ralchev K; Dimitrov V; Bozhimirov S; Georgieva E; Berger MR
Oncol Rep; 2008 Jul; 20(1):3-11. PubMed ID: 18575712
[TBL] [Abstract][Full Text] [Related]
35. Mutations in APC, CTNNB1 and K-ras genes and expression of hMLH1 in sporadic colorectal carcinomas from the Netherlands Cohort Study.
Lüchtenborg M; Weijenberg MP; Wark PA; Saritas AM; Roemen GM; van Muijen GN; de Bruïne AP; van den Brandt PA; de Goeij AF
BMC Cancer; 2005 Dec; 5():160. PubMed ID: 16356174
[TBL] [Abstract][Full Text] [Related]
36. Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality.
Al-Mulla F; Going JJ; Sowden ET; Winter A; Pickford IR; Birnie GD
J Pathol; 1998 Jun; 185(2):130-8. PubMed ID: 9713338
[TBL] [Abstract][Full Text] [Related]
37. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
Wu X; Lu XH; Xu T; Qian JM; Zhao P; Guo XZ; Yang XO; Jiang WJ
Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
[TBL] [Abstract][Full Text] [Related]
39. Aberrations of the K-ras, p53, and APC genes in extrahepatic bile duct cancer.
Suto T; Habano W; Sugai T; Uesugi N; Funato O; Kanno S; Saito K; Nakamura Si
J Surg Oncol; 2000 Mar; 73(3):158-63. PubMed ID: 10738270
[TBL] [Abstract][Full Text] [Related]
40. Fecal multiple molecular tests to detect colorectal cancer in stool.
Calistri D; Rengucci C; Bocchini R; Saragoni L; Zoli W; Amadori D
Clin Gastroenterol Hepatol; 2003 Sep; 1(5):377-83. PubMed ID: 15017656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
